US Patent 8404837 Quinoline derivatives as P13 kinase inhibitors
Patent 8404837 was granted and assigned to GlaxoSmithKline on March, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8404837 Quinoline derivatives as P13 kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
